There are 749 resources available
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Presenter: Fatima Cardoso
Session: To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Resources:
Slides
Webcast
Immunotherapy in gastroesophageal cancers: Present and future
Presenter: Florian Lordick
Session: Immunotherapy in gastroesophageal cancers: Present and future
Resources:
Slides
Webcast
Effects of immune architecture on response to adjuvant capecitabine in triple negative breast cancer (FinXX trial)
Presenter: Douglas Hinerfeld
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Trastuzumab emtansine (T-DM1) vs trastuzumab (H) in Chinese patients (pts) with residual invasive disease after neoadjuvant chemotherapy for HER2-positive breast cancer (BC) in the phase III KATHERINE study
Presenter: Chiunsheng Huang
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Subgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries
Presenter: Hiroji Iwata
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Talazoparib (TALA) vs physician’s choice of chemotherapy (PCT) in Asian patients (Pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCA1/2mut): Data from phase III EMBRACA
Presenter: Kyung-Hun Lee
Session: Proffered paper session - Breast cancer
Resources:
Slides
Setting up breast services improvements and learning bridges in Kyrgyzstan: The SILK project
Presenter: Olivia Pagani
Session: Mini Oral session - Public policy
Resources:
Slides
Webcast
Timeliness of lung cancer treatment utilizing the rapid access lung cancer clinic in a regional Australian Hospital
Presenter: Nguyen Chau
Session: Mini Oral session - Public policy
Resources:
Slides
Webcast
Molecular profiling and treatment patterns of advanced salivary gland cancers in head and neck region
Presenter: Vikas Talreja
Session: Mini Oral session - Head and neck cancer
Resources:
Slides
Webcast
Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy
Presenter: Jingjing Miao
Session: Mini Oral session - Head and neck cancer
Resources:
Slides
Webcast